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a b s t r a c t 
Atypical hemangiomas of the spine can mimic metastatic lesions on magnetic resonance 
imaging, therefore making this distinction is a diagnostic challenge. In most cases, this co- 
nundrum can usually be solved with positron emission tomography/computed tomogra- 
phy images, because hemangiomas do not usually present with increased uptake while 
metastatic lesions do. Here we present a case of a patient with a unique diagnosis, myx- 
oid liposarcoma, in which the vertebral metastatic lesion did not present with increased 
uptake in positron emission tomography/computed tomography scans. While keeping the 
imaging particularity of this rare sarcoma in mind, proceeding with a biopsy when the sus- 
picion of metastasis remains high will help elucidate the diagnosis and allow for proper 
management. 
© 2019 The Authors. Published by Elsevier Inc. on behalf of University of Washington. 
This is an open access article under the CC BY-NC-ND license. 
( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 
Introduction 
Intraosseous hemangiomas (IH) are benign vascular tumors 
which very rarely cause symptoms and are often found in- 
cidentally. Based on postmortem studies, it is estimated that 
they are found in 11% of the population [1] . IH most commonly 
occur between the fourth and sixth decade with a slight fe- 
male predominance and 80% of cases will be localized to the 
skull or spine [2,3] , where they are usually located in the ver- 
tebral body. Although they are most commonly found in the 
thoracic region, multiple locations can be present in up to 
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30% of cases [4,5] . IH have a classic radiologic appearance due 
to its histological content, which consists of a hamartoma- 
tous lesion with well-differentiated thin-walled vessels and 
a nonvascular component. The latter of which includes dif- 
ferent percentages of fat, fibrous tissue, bone, hemosiderin, 
and smooth muscle [2,4] . The spatial arrangement of such 
components within the vertebral body translates into several 
classic radiologic findings. On radiographs, vertical striations 
and honeycomb appearance can be seen, while on computed 
tomography (CT) polka-dots are observed [6] . Magnetic reso- 
nance imaging visualizes IH as hyperintense T1-sequence le- 
sions due to its lipomatous components and as hyperintense 
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Fig. 1 – MRI of the lumbar spine (May 2018). Images depict findings consistent with a benign fracture and compression 
deformity of the superior endplate of L5 and a sharply marginated enhancing osseous lesion ( ∗) in the L3 vertebral body. 
MRI, magnetic resonance imaging. 
T2-sequence lesions due to the vascular portion, which also 
causes these lesions to be seen as enhancing under contrast 
administration [7–9] . On 18F-FGD positron emission tomogra- 
phy/CT (PET/CT) scans IH are visualized as cold lesions with 
no increased uptake above background. There have been some 
reported cases of increased uptake of rib hemangiomas and 
spine hemangiomas, however this is usually not the case [10–
13] . 
An atypical hemangioma is a hemangioma that does 
not present with a classical imaging appearance and may 
resemble a more aggressive type of lesion [14] . Different dis- 
tributions of tissue content within these lesions results in this 
idiosyncrasy. Atypical hemangiomas with low lipomatous 
percentage may present as hypointense on T1-sequence, but 
because of the lesion’s vascular component, it can display 
T2-sequence hyperintensity with enhancement under con- 
trast, thus resembling a metastatic lesion and clouding the 
difference between the 2 [15,16] . Adding to this diagnostic 
challenge, an atypical hemangioma may also present with ag- 
gressive features such as cortical destruction, bone expansion, 
and even invasion of the spinal canal. These are observations 
frequently associated with metastatic processes [2,17] . Prior 
studies have shown that new MRI techniques using diffusion 
weighted imaging combined with apparent diffusion coef- 
ficient maps and T1-weighted dynamic contrast-enhancing 
may help resolve this diagnostic problem, but unfortunately 
these techniques are not part of the standard of care [18,19] . 
Case report 
A 31-year-old female with a history of a myxoid liposarcoma 
(MLS) excised from the left thigh, the primary location of the 
tumor, 2 years prior was under our care for a recurrent lo- 
calized tumor with no evidence of other metastatic disease. 
The primary tumor presented on MRI as a soft tissue localized 
lesion hypointense in T1-weighted sequences, hyperintense 
in T2 with fat suppression ones and with heterogeneous en- 
hancement with gadolinium contrast. She had received sys- 
temic treatment and awaited surgical resection and endopros- 
thetic reconstruction of this lesion. The patient presented to 
our clinic in May 2018, prior to her procedure, with acute back 
pain that developed during physical activity without any sig- 
nificant trauma. The pain was severe and included the lower 
back but did not have radiation to the lower extremities or any 
other neurologic findings. Radiographs of the lumbar spine 
obtained on that same date, showed an age indeterminate 
compression deformity of the L5 vertebral body involving the 
superior endplate, no signs of osteoporosis were noted. The 
radiographic image and the patient’s symptoms prompted 
the acquisition of an MRI with and without gadolinium con- 
trast, a week after the initial presentation, which confirmed a 
compression deformity and fracture of the L5 vertebral body, 
which could explain the patient’s symptoms, and ruled out 
a neoplastic process at L5. Additional findings included a T1- 
sequnce hypointense and T2-sequence hyperintense lesion, 
enhancing under contrast in the L3 vertebral body with sharp 
margins. The lesion measured 1.24 ×1.10 ×0.93 cm and was 
reported as potentially representing a metastatic lesion or 
an atypical vertebral body hemangioma ( Fig. 1 ). A PET/CT 
scan was obtained 2 weeks after the initial presentation and 
showed increased uptake of the fractured L5 body but failed 
to show significant findings at the L3 vertebral body ( Fig. 2 ). 
The case was presented at our sarcoma tumor board and we 
decided to delay the patient’s femur resection and instead per- 
form a CT-guided biopsy of the L3 vertebral body lesion as it 
would change surgical plan ( Fig. 3 ). Histopathologic analysis of 
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Fig. 2 – PET/CT (May 2018) showing increased uptake within the L5 vertebral body, related to moderate compression fracture 
deformity. No abnormal uptake in the L3 vertebral body. PET/CT, positron emission tomography/computed tomography. 
Fig. 3 – CT images of the L3 vertebral body (May 2018), depicting the lesion’s unspecific appearance ( ∗) in a bone window (A), 
a soft tissue window (B) and the biopsy of the lesion with a percutaneous needle CT-guided technique (C). 
the specimen obtained 3 weeks after the initial presentation, 
revealed a blood clot and medullary bone with no evidence of 
malignancy ( Fig. 4 ). We later proceeded with her proximal fe- 
mur resection and the preprocedure MRI showed no change 
in her L3 lesion at 2 months from the patient’s presentation. 
The procedure was performed without complications and a 
margin-free resection was achieved. 
Four months from the patient’s initial presentation for 
acute back pain, a new PET/CT showed increased activity in 
the left medial thigh, a new large hypermetabolic left axil- 
lary lymph node, continued visualization of the L5 compres- 
sion fracture, and no evidence of increased activity at L3. Work 
up of her left axillary lymph node verified metastatic spread 
of her MLS. After removal of this node, follow up PET/CT re- 
vealed a new mass in her left ovary, but again did not ap- 
preciate any significant findings at the L3 vertebral body at 
7 months from presentation ( Fig. 5 ). Although a pelvic MRI also 
at 7 months from the initial back pain symptoms, showed the 
ovarian mass was benign, we found that the L3 vertebral le- 
sion’s diameter had nearly tripled from 1.1 to 3.1cm and occu- 
pied the entire vertebral body ( Fig. 6 ). 
Fig. 4 – Percutaneous biopsy of L3 lesion pathology 
examination depicting normal bone marrow elements and 
blood (May 2018). No evidence of malignancy. [H&E, 20 ×]. 
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Fig. 5 – PET/CT (December 2018, post proximal femur resection) noted postoperative changes in the left thigh with a 
proximal femur reconstruction and a SUV maximum 3.4. No abnormal uptake at the L3 level. PET/CT, positron emission 
tomography/computed tomography. 
Fig. 6 – MRI of the lumbar spine (December 2018). The superior endplate fracture of L5 has healed. There is no evidence of 
underlying neoplastic disease. The marrow signal is normal at the L5 level. Interval increase in size of L3 lesion ( ∗) from 
1.1 cm in diameter to 3.1 cm. The lesion now extends from the superior to the inferior endplate and the posterior cortex to 
nearly the anterior cortex involving nearly the entire vertebral body. MRI, magnetic resonance imaging. 
The sarcoma tumor board reviewed the patient’s case again 
and now strongly suspected that the L3 lesion was a site of 
metastasis. Kyphoplasty and radiofrequency ablations were 
performed 7 months after presentation and a histopathologic 
sample obtained during the procedure confirmed this as a 
metastatic lesion of her primary MLS. A moderately cellular 
neoplasm with myxoid stroma, arborizing capillary vascula- 
ture, and spindled to round tumor cells with scant cytoplasm, 
and hyperchromatic nuclei were observed in the sample with 
involvement of the bone marrow ( Fig. 7 ). 
The patient completed targeted lumbar radiation therapy. 
Follow up imaging of L3 almost a year from the initial symp- 
toms has shown an increase in abnormal signal/marrow re- 
placement, extending into the left pedicle and periphery of 
the vertebral body. Surveillance imaging has also discovered 
a new site in the left buttocks concerning for soft tissue 
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Fig. 7 – Open biopsy pathology images showing round to oval-shaped nonlipogenic cells and small lipoblasts embedded in 
a prominent myxoid stroma (December 2018) [H&E, 20 ×] (A). High-power view of the round/oval nonlipogenic cells and 
small lipoblasts within myxoid stroma with delicate, branching vessels [H&E, 40 ×] (B). High power view of focal area of 
increased cellularity with retention intercellular myxoid stroma [H&E, 40 ×] (C). 
metastasis. Now 32 years old, our patient is being evaluated 
for cellular therapy and a new systemic chemotherapy. 
Discussion 
Atypical hemangiomas and metastatic lesions, as previously 
mentioned, share common imaging features, such as signs of 
aggressiveness, similar patterns of intensity on T1 and T2 se- 
quences, and enhancement seen on MRI [2,15–17] . They even 
present with similar age demographics: fourth to sixth decade 
for hemangiomas and fourth to fifth decades for MLS [2,26] . 
Both diagnoses should be considered a part of the differential, 
especially in patients with a known primary malignancy pre- 
senting with a vertebral lesion. More than 50% of the primary 
cancers will develop secondary bone lesions [20] . For many of 
these primary cancer types, studies have shown that PET/CT 
scans have a high specificity and sensitivity for detecting bone 
metastases when compared to other imaging modalities. Most 
tumor cells have increased glucose metabolism that causes 
the tracer to accumulate inside of these cells [21] . The majority 
of metastatic lesions analyzed with a PET/CT scan will display 
uptake, while typical and atypical hemangiomas usually have 
no increased signal. Therefore, PET/CT’s are normally an im- 
portant tool in differentiating metastases and hemangiomas. 
However, in the case presented, the patient had a unique 
primary cancer type, MLS, which has many atypical and pe- 
culiar attributes, especially when it comes to PET/CT. MLS un- 
dergoes a different pattern of metastasis than other soft tissue 
malignancies. While most soft tissue cancers primarily spread 
to the lungs, MLS spreads more often to bone and lipomatous 
soft tissue in the retroperitoneum, axilla and mesentery, and 
classically the paraspinal muscles [ 22 ,23 ]. A third of MLS pa- 
tients will progress to stage IV disease, with 14% of these pa- 
tients having bone secondary lesions in a spine location [24] . 
The diagnosis of vertebral lesions secondary to MLS with 18F- 
FGD PET/CT or bone scintigraphy have shown low sensitivity, 
14% and 16%, respectively [25] , even though PET/CT are effec- 
tive in highlighting primary and metastatic soft tissue sites 
of MLS. Schwab et al suggested that, in the setting of MLS, 
myxoid stroma in the vertebral lesion potentially prevents la- 
beled glucose from reaching cells in sufficient quantity to be 
detected by the scanner, thus accounting for such a low rate 
of detection by PET/CT [25] . The recommended method for de- 
tection of vertebral metastases, with the highest sensitivity, in 
the setting of MLS is the MRI [26] . 
If suspicion of metastasis remains high, it is recommended 
to proceed with a biopsy of the vertebral lesion and may even 
require and open biopsy. A prior study has shown a 10% rate 
of samples with insufficient material for histopathologic diag- 
nosis with CT-guided biopsies of the spine, so having a pathol- 
ogist to confirm the adequacy of sample on site can help lower 
this rate [27] . The overall accuracy for the diagnosis of spinal 
metastatic lesions with CT-guided biopsies ranges from 90% 
to 95% with a complication rate of < 5% [28] . 
Conclusion 
Atypical hemangiomas and MLS secondary spine lesions of- 
ten present with many similar characteristics on MRI. While 
for most primary cancer types, PET/CT is useful in differentiat- 
ing the 2, it is not helpful in the setting of MLS due to the tumor 
cell’s reduced ability to absorb labeled glucose in the spine 
location. Here we presented this unusual scenario where an 
atypical hemangioma and metastatic process mimicked one 
another. Our patient had multiple negative PET/CT and no 
definitive MRI for over 6 months. It was not until an MRI, 
performed 2 weeks after a negative PET/CT, showed progres- 
sion could we ultimately say there was a metastatic bone le- 
sion. Ultimately, only an accurate biopsy confirmed metastatic 
spread to the vertebral body. 
Sarcoma multidisciplinary treatment teams could face 
similar diagnostic challenges, analogous to the case pre- 
sented. Making a distinction between a localized and a stage 
IV sarcoma has several implications in terms of treatment op- 
tions and prognosis. In this case based on a questionable MRI 
with a negative PET/CT and negative biopsy the decision was 
made to proceed forward with resection and megaprosthetic 
reconstruction in the setting of previous radiation which has 
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significant risks associated. Consequently, it is paramount to 
arrive at a definitive diagnosis in the setting of MLS, utilizing 
MRI surveillance and biopsy when suspicion for metastasis is 
high. 
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